BioArctic AB (publ) (BRCTF)
BioArctic AB (publ) Statistics
Share Statistics
BioArctic AB (publ) has 88.53M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 88.53M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -100.98 and the forward PE ratio is null. BioArctic AB (publ)'s PEG ratio is 0.57.
| PE Ratio | -100.98 |
| Forward PE | n/a |
| PS Ratio | 69.48 |
| Forward PS | n/a |
| PB Ratio | 19.98 |
| P/FCF Ratio | -56.53 |
| PEG Ratio | 0.57 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioArctic AB (publ).
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.75 |
| Quick Ratio | 5.75 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | -0.29 |
| Debt / FCF | -0.17 |
| Interest Coverage | -123.59 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2,405,158.88 |
| Profits Per Employee | $-1,654,943.93 |
| Employee Count | 107 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -12.44M |
| Effective Tax Rate | 6.56% |
Stock Price Statistics
The stock price has increased by 15.15% in the last 52 weeks. The beta is -0.67, so BioArctic AB (publ)'s price volatility has been lower than the market average.
| Beta | -0.67 |
| 52-Week Price Change | 15.15% |
| 50-Day Moving Average | 19.71 |
| 200-Day Moving Average | 17.59 |
| Relative Strength Index (RSI) | 69.3 |
| Average Volume (20 Days) | 150 |
Income Statement
In the last 12 months, BioArctic AB (publ) had revenue of 257.35M and earned -177.08M in profits. Earnings per share was -2.
| Revenue | 257.35M |
| Gross Profit | 230.37M |
| Operating Income | -228.51M |
| Net Income | -177.08M |
| EBITDA | -187.67M |
| EBIT | -187.67M |
| Earnings Per Share (EPS) | -2 |
Balance Sheet
The company has 512.93M in cash and 54.23M in debt, giving a net cash position of 458.7M.
| Cash & Cash Equivalents | 512.93M |
| Total Debt | 54.23M |
| Net Cash | 458.7M |
| Retained Earnings | n/a |
| Total Assets | 1.11B |
| Working Capital | 835M |
Cash Flow
In the last 12 months, operating cash flow was -316.33M and capital expenditures 0, giving a free cash flow of -316.33M.
| Operating Cash Flow | -316.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -316.33M |
| FCF Per Share | -3.58 |
Margins
Gross margin is 89.51%, with operating and profit margins of -88.79% and -68.81%.
| Gross Margin | 89.51% |
| Operating Margin | -88.79% |
| Pretax Margin | -73.64% |
| Profit Margin | -68.81% |
| EBITDA Margin | -72.92% |
| EBIT Margin | -88.79% |
| FCF Margin | -122.92% |
Dividends & Yields
BRCTF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BRCTF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 5.17 |
| Piotroski F-Score | 1 |